Pal Prodipto, Xi Huifeng, Sun Guangyun, Kaushal Ritesh, Meeks Joshua J, Thaxton C Shad, Guha Saurav, Jin Carol H, Suarez Brian K, Catalona William J, Deka Ranjan
Department of Environmental Health, Center for Genome Information, University of Cincinnati Medical Center, OH 45267-0056, USA.
Hum Genet. 2007 Nov;122(3-4):251-9. doi: 10.1007/s00439-007-0394-3. Epub 2007 Jun 26.
Two of the classical kallikrein genes KLK3 and KLK2 on 19q13.4 are plausible candidates in prostate cancer susceptibility. They are expressed almost exclusively in prostate tissue. We have performed a comprehensive analysis of association of variants in these two genes with prostate cancer among men of European descent using a tagging SNP approach. Thirteen SNPs selected from the HapMap database were analyzed in a sample of 596 histologically verified prostate cancer cases and 567 ethnically matched controls. Five SNPs showed significant association at single marker level. Linkage disequilibrium (LD) analysis revealed four LD blocks. We performed a haplotype analysis within each LD block. A major haplotype in block 1 that contains the first two significantly associated SNPs was significantly underrepresented in the prostate cancer cases; a second haplotype in block 3 also showed significant frequency differences between cases and controls. Four of the studied SNPs show positive associations with serum PSA levels. A structure analysis revealed no population stratification in our samples that could have confounded the association results. These findings suggest a plausible role of kallikrein gene variants in the etiology of prostate cancer among men of European ancestry.
位于19q13.4的两个经典激肽释放酶基因KLK3和KLK2是前列腺癌易感性的可能候选基因。它们几乎只在前列腺组织中表达。我们使用标签单核苷酸多态性(tagging SNP)方法,对欧洲裔男性中这两个基因的变异与前列腺癌的关联性进行了全面分析。在596例经组织学证实的前列腺癌病例和567例种族匹配的对照样本中,分析了从HapMap数据库中选取的13个单核苷酸多态性。5个单核苷酸多态性在单标记水平显示出显著关联。连锁不平衡(LD)分析揭示了4个LD块。我们在每个LD块内进行了单倍型分析。第1个LD块中包含前两个显著关联单核苷酸多态性的一个主要单倍型在前列腺癌病例中显著减少;第3个LD块中的第二个单倍型在病例和对照之间也显示出显著的频率差异。4个研究的单核苷酸多态性与血清前列腺特异抗原(PSA)水平呈正相关。结构分析表明我们的样本中不存在可能混淆关联结果的人群分层。这些发现提示激肽释放酶基因变异在欧洲血统男性前列腺癌病因学中可能发挥作用。